Trial watch: somatostatin analogue shows promise in Cushing's disease.
D017326:Clinical Trials, Phase III as Topic / Q000379:methods*; D006801:Humans; D047748:Pituitary ACTH Hypersecretion / Q000188:drug therapy* / Q000276:immunology*; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use
D013004:Somatostatin; C517782:pasireotide